Veralto Reports Third Quarter 2026 Results

Veralto posts strong Q3 growth, raises 2026 earnings and sales guidance.

What the company is saying

Veralto reports a 7.5% year-over-year increase in Q3 2026 sales to $1,509 million, emphasizing broad-based growth and strong operating leverage. The company highlights a 19.7% operating profit margin and a 25.6% non-GAAP adjusted operating profit margin, with net earnings of $253 million ($1.03 per diluted share) and adjusted net earnings of $290 million ($1.18 per share). CEO Jennifer L. Honeycutt frames the results as 'outstanding,' attributing performance to healthy demand, especially in Water Quality, and successful capital allocation. Veralto underscores its $1.1 billion deployment on four acquisitions and $550 million in share repurchases, as well as early progress on a Cost Optimization Program expected to save $10–$15 million in 2026. The company raises its full-year adjusted EPS guidance to $4.49–$4.52 (15–16% growth) and core sales growth guidance to 4.2–4.5%. The tone is confident, with forward-looking statements grounded in realised quarterly results.

What the data suggests

Q3 2026 sales reached $1,509 million, up 7.5% year-over-year, with non-GAAP core sales growth of 5.1%. Operating profit margin was 19.7%, and non-GAAP adjusted operating profit margin was 25.6%. Net earnings were $253 million ($1.03 per diluted share), while adjusted net earnings were $290 million ($1.18 per share). Operating cash flow was $323 million, and non-GAAP free cash flow was $304 million. The Water Quality segment posted 6.4% core sales growth, and acquisitions contributed 2.3% to total sales growth. Adjusted operating margin expanded by 170 basis points, and adjusted EPS increased 19.2% year-over-year. The company deployed $1.1 billion on four acquisitions and repurchased $550 million of shares (2.4% of shares as of February 13, 2026). Guidance for Q4 2026 anticipates 5.5–6.5% core sales growth and adjusted EPS of $1.13–$1.16. Full-year 2026 guidance is raised for adjusted EPS ($4.49–$4.52) and core sales growth (4.2–4.5%). The data shows robust realised growth and cash generation, with forward-looking targets supported by recent performance.

Analysis

The announcement's tone is positive but proportionate to the strong realised financial results disclosed for Q3 2026. The company provides detailed, audited figures for sales, profit margins, net earnings, cash flow, and segment growth, all showing clear year-over-year improvement. While some forward-looking statements are present (notably raised guidance for Q4 and full-year 2026), these are typical for a quarterly earnings release and are supported by the strong current performance. The $1.1 billion in acquisitions and $550 million in share repurchases are significant capital outlays, but the immediate financial benefits are evident in the reported results, and the acquisitions are already closed. There is no evidence of narrative inflation or exaggerated claims; the CEO's positive language is justified by the data. The gap between narrative and evidence is minimal, with all major claims supported by disclosed numbers.

Risk flags

• ●Integration risk from four acquisitions totaling $1.1 billion remains, as realising full synergies and maintaining performance across acquired businesses can be challenging. The announcement does not detail integration progress or risks.
• ●The Cost Optimization Program's expected $10–$15 million in 2026 savings is not yet realised; if execution falters or savings are delayed, margin expansion could be less than forecast.
• ●Raised guidance for adjusted EPS and core sales growth relies on continued demand strength, particularly in Water Quality and Product Quality and Innovation segments. Any macroeconomic slowdown or sector-specific headwinds could pressure these targets.
• ●Significant capital outlays for acquisitions and $550 million in share repurchases reduce financial flexibility if market conditions deteriorate or integration costs rise unexpectedly.
• ●Forward-looking statements on Q4 and full-year performance are projections, not guarantees. If actual results fall short, investor confidence could be impacted.

Bottom line

Veralto delivered strong Q3 2026 results, with 7.5% sales growth, higher margins, and robust cash flow, supporting its decision to raise full-year earnings and sales guidance. The company has been aggressive in deploying capital, closing four acquisitions for $1.1 billion and buying back $550 million in shares, which signals confidence but also introduces integration and balance sheet risks. While the outlook for Q4 and the full year is positive and grounded in recent performance, some targets—such as cost optimization savings—remain to be realised. Investors should focus on the company's ability to integrate acquisitions, sustain demand in core segments, and deliver on raised guidance. The key takeaway is that Veralto's operational momentum is real, but execution on recent investments and cost initiatives will determine whether this trajectory continues.

Announcement summary

(NYSE:VLTO) Veralto reported third quarter 2026 sales of $1,509 million, representing a 7.5% year-over-year increase, with non-GAAP core sales growth of 5.1%. Operating profit margin for the quarter was 19.7%, while non-GAAP adjusted operating profit margin reached 25.6%. Net earnings for the quarter were $253 million, or $1.03 per diluted common share, and non-GAAP adjusted net earnings were $290 million, or $1.18 per diluted common share. Operating cash flow for the quarter was $323 million, and non-GAAP free cash flow was $304 million. Year-to-date as of October 28, 2026, Veralto deployed $1.1 billion on four strategic acquisitions: In-Situ, GlobalVision, Alfaa UV, and Cleanwater1, with the Cleanwater1 acquisition closing on October 5, 2026. The company repurchased $550 million of shares, representing 2.4% of outstanding shares as of February 13, 2026. Early gains from the Cost Optimization Program are expected to deliver full year 2026 savings of $10-$15 million. Water Quality segment core sales grew 6.4% in the quarter, and acquisitions contributed 2.3% to total sales growth. Adjusted operating margin expanded by 170 basis points and adjusted earnings per share increased 19.2% year-over-year. The company raised its full year 2026 adjusted earnings per share guidance to $4.49 to $4.52, representing 15% to 16% growth over the prior year, and increased its non-GAAP core sales growth guidance to 4.2% to 4.5%. Fourth quarter 2026 non-GAAP core sales growth is anticipated to be 5.5% to 6.5% year-over-year, with adjusted operating profit margin expected to be approximately 24.5%. Fourth quarter adjusted diluted earnings per share guidance is $1.13 to $1.16. Free cash flow conversion guidance was raised to greater than 105% of GAAP net earnings. The company has annual sales of approximately $5.5 billion and a global team of approximately 17,000 associates. Jennifer L. Honeycutt, President and Chief Executive Officer, stated that the company delivered outstanding third-quarter results, with broad-based sales growth and strong operating leverage, and highlighted the company's disciplined approach to capital allocation and long-term value creation strategy.

Disagree with this article?